KN046 shows tolerability and activity in TNBC

Nat Rev Clin Oncol. 2024 Apr;21(4):251. doi: 10.1038/s41571-024-00872-4.
No abstract available

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Cell Line, Tumor
  • Cell Proliferation
  • Humans
  • Triple Negative Breast Neoplasms* / drug therapy
  • Triple Negative Breast Neoplasms* / genetics

Substances

  • Antineoplastic Agents